… equivalent efficacy in patients who received erlotinib as third-line compared with those who
received erlotinib as second-line [13, 14]. Thus, erlotinib is a candidate of the standard third- …

… Background: Erlotinib and gefitinib … erlotinib is approximately 3.5 times higher than that of
gefitinib when administered at the respective approved dose, treatment with low-dose erlotinib …

… Therefore, we performed this prospective study to investigate the efficacy and tolerability
of erlotinib monotherapy in Japanese patients with wild-type EGFR as a potential therapeutic …

… of erlotinib for advanced non-small-cell lung cancer. Overall, the studies found that erlotinib,
… studies evaluating erlotinib as monotherapy have expanded the role of erlotinib to the first-…

… erlotinib is difficult to detect in erlotinib-sensitive tumor, we investigated the efficacy of erlotinib
plus bevacizumab in erlotinib-… Erlotinib monotherapy is approved for treatment of patients …

… In our study, monotherapy with erlotinib achieved an overall response of 35.7% and a DCR
of 76.8% in 112 Chinese patients, which is significantly higher than the 12 to 19% response …

… , which is an HGF expression positive gastric cell line. Effect of monotherapy with BEV or …
+ERL, we examined the effect of each as a monotherapy. In the HCC827 xenograft model, ERL …

… of Part A was performed to assess afatinib monotherapy. Results: Patient enrolment into Part
A was … Conclusions: Afatinib monotherapy demonstrated encouraging activity in treatment-…

… The SR identified two such studies, one comparing erlotinib plus bevacizumab versus
erlotinib monotherapy Citation19 and a second comparing gefitinib plus concurrent or sequential …

… Lung cancer is a leading cause of cancer-related death, with … -cell lung cancer (NSCLC)
represents 85% of all lung cancers. For … Phase I and II studies of tivantinib as monotherapy or in …